Since super-enhancers (SEs) have been shown to drive high levels of oncogenic gene expression to maintain cancer cell survival (Hnisz et al., 2013; Loven et al., 2013), we next set out to determine whether JMJD1C and RUNX1 regulate gene expression by binding to SEs. The gene discussed is JMJD1C; the disease is cancer.